Singing Machine Co. Enters Material Definitive Agreement
Ticker: RIME · Form: 8-K · Filed: Jun 27, 2024 · CIK: 923601
| Field | Detail |
|---|---|
| Company | Singing Machine Co Inc (RIME) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $1,080,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: SMCI
TL;DR
SMCI just signed a big deal, details TBD.
AI Summary
On June 26, 2024, The Singing Machine Company, Inc. entered into a material definitive agreement. The company, headquartered in Fort Lauderdale, FL, filed an 8-K report detailing this agreement. Specific financial terms or counter-parties were not disclosed in the provided excerpt.
Why It Matters
This filing indicates a significant new contract or partnership for Singing Machine Company, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, but the lack of specific details about the agreement's nature, terms, and counter-party introduces uncertainty.
Key Players & Entities
- The Singing Machine Company, Inc. (company) — Registrant
- June 26, 2024 (date) — Date of earliest event reported
- Fort Lauderdale, FL (location) — Principal Executive Offices
FAQ
What type of material definitive agreement did The Singing Machine Company, Inc. enter into?
The filing states that The Singing Machine Company, Inc. entered into a material definitive agreement on June 26, 2024, but the specific nature of the agreement is not detailed in the provided excerpt.
Who is the counter-party to this material definitive agreement?
The provided excerpt does not disclose the name of the other party involved in the material definitive agreement.
What are the key financial terms of this agreement?
The excerpt does not provide any specific financial terms, dollar amounts, or other financial details related to the material definitive agreement.
When was this agreement officially entered into?
The agreement was entered into on June 26, 2024, which is the date of the earliest event reported in the filing.
What is the principal business address of The Singing Machine Company, Inc.?
The principal executive offices of The Singing Machine Company, Inc. are located at 6301 NW 5th Way, Suite 2900, Fort Lauderdale, FL 33309.
Filing Stats: 935 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-06-27 17:07:27
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share MICS The Nasdaq Stock Mar
- $1,080,000 — ng an aggregate offering price of up to $1,080,000 (the "Shares") from time to time, throu
Filing Documents
- form8-k.htm (8-K) — 47KB
- ex1-1.htm (EX-1.1) — 264KB
- ex5-1.htm (EX-5.1) — 11KB
- ex5-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-025467.txt ( ) — 558KB
- mics-20240626.xsd (EX-101.SCH) — 3KB
- mics-20240626_lab.xml (EX-101.LAB) — 33KB
- mics-20240626_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2024 The Singing Machine Company, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-41405 95-3795478 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 6301 NW 5 th Way , Suite 2900 Fort Lauderdale , FL 33309 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: (954) 596-1000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share MICS The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01 Entry into a Material Definitive Agreement. On June 26, 2024, The Singing Machine Company, Inc. (the "Company") entered into an At-the-Market Issuance Sales Agreement (the "Sales Agreement") with Ascendiant Capital Markets, LLC, as sales agent (the "Agent") to sell shares of its common stock, par value $0.01 per share (the "Common Stock"), having an aggregate offering price of up to $1,080,000 (the "Shares") from time to time, through an "at the market offering" (the "ATM Offering") as defined in Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"). On June 27, 2024, the Company filed a prospectus supplement with the Securities and Exchange Commission ("SEC") relating to the offer and sale of up to $1,080,000 of Common Stock in the ATM Offering. The offer and sale of the Shares will be made pursuant to the Company's effective "shelf" registration statement on Form S-3 and an accompanying base prospectus contained therein (File No. 333-269183) filed with the SEC on January 11, 2023 and declared effective by the SEC on January 20, 2023. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the Shares, nor shall there be any offer, solicitation or sale of the Shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. upon the Company's instructions, consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and rules of the Nasdaq Stock Market. The Company will set the parameters for sales of the Shares, including the number of Shares to be sold, the time period during which sales are requested to be made, any limitation on the number of Shares that may be sold in one trading day, and any minimum price below which sales may not be made. Under the Sales Agreement, the Agent may sell the Shares by any method permitted by law deemed to be an "at the market offering," as defined in Rule 415 of the Securities Act. The Company or the Agent may, upon written notice to the other party in accordance with the terms of the Sales Agreement, suspend offers and sales of the Shares. The Company and the Agent each have the right, in its sole discretion, to terminate the Sales Agreement pursuant to the terms and subject to the conditions set forth in the Sales Agreement. The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement which is attached hereto as Exhibit 1.1. A copy of the opinion of Sichenzia Ross Ference Carmel LLP relating to the validity of the Shares that may be sold pursuant to the Sales Agreement is filed herewith as Exhibit 5.1. Item 9.01 Financial Statement